We found that mRNA expression of CCNB2, CDC20 and MYBL2 was significantly different in primary, recurrent and secondary GBM (primary > recurrent>secondary), suggesting that CCNB2, CDC20 and MYBL2 might be involved in the origin of GBM. The gene discussed is MYBL2; the disease is glioblastoma.